Medistim ASA (FRA:MD1)
€ 12.15 -0.25 (-2.02%) Market Cap: 226.29 Mil Enterprise Value: 216.00 Mil PE Ratio: 23.78 PB Ratio: 5.97 GF Score: 90/100

Q3 2022 Medistim ASA Earnings Call Transcript

Oct 28, 2022 / NTS GMT
Release Date Price: €21.5 (-3.37%)
Kari Krogstad
Medistim ASA - President and CEO

So a very good morning, everybody. Thank you very much for joining us for Medistim's third-quarter presentation this year. My name is Kari Krogstad, and, as usual, together with my CFO, Thomas Jakobsen, we are going to take you through our quarterly results. And we are going to follow our agenda, starting with the highlights, and then Thomas will continue with an in-depth go-through on the financial statements, and I will return with some comments to the business segments and implementing our strategy.

So this third quarter, again, I'm very happy to be able to say that this is another very strong quarter from Medistim, and we can see a 14% growth on our revenues. And this means that, I think it's fair to say, that we have established a quarterly sales above NOK100 million for a quarter. And as I believe most of you are aware, we are a business focusing on transit time flow measurements in intraoperative surgery. And the majority of our business today is really concentrated around this flow measurement technology.

It is also our strategy to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot